Urothelial carcinoma (UC) is common cancer worldwide. The molecular aberrations
regarding tumor progression remain unclear. Pericellular proteolysis is crucial in …

Dipeptidyl peptidase III (DPP3), a zinc-dependent metallopeptidase, is upregulated in a
variety of malignancies. However, little is known about its roles in the pathogenesis of these …

Dipeptidyl peptidase 9 (DPP9) is encoded by DPP9, which belongs to the DPP4 gene
family. Proteins encoded by these genes have unique peptidase and extra‐enzymatic …

In an attempt to disclose mechanisms of bladder carcinogenesis and discover novel target
molecules for development of treatment, we applied a cDNA microarray to screen genes that …

Simple Summary Colorectal cancer (CRC) is one of the most common cancers, which has a
poor prognosis and is prone to recurrence and metastasis. DPP7 is a prolyl peptidase …

The object of the present study was to identify markers for predicting urinary bladder cancer
progression by comparative proteome analysis of bladder cancers and paired normal …

Abstract Dipeptidyl peptidase IV (DPPIV/CD26) is a multifunctional protein with intrinsic
peptidase activity that inactivates or degrades some bioactive peptides. It is the main cellular …

Bladder cancer is the second most common genitourinary cancer worldwide, yet its
oncogenic origins remain poorly understood. The cancer-testis antigen DEPDC1 was shown …

Abstract DEP domain containing 1 (DEPDC1) is a newly identified cancer-related and cell
cycle related gene and has been demonstrated as a novel therapeutic target for bladder …

Urinary bladder cancer (UBC) is a common malignant tumor with high incidence. Advances
in the diagnosis and treatment of this disease demand the identification of novel therapeutic …